Associated Papers
Possible Use of Non-purine Selective Xanthine Oxidoreductase Inhibitors for Prevention of Exercise-induced Acute Kidney Injury Associated with Renal Hypouricemia.
Aizawa C et al.
Internal Medicine (tokyo, Japan), 2023
Substantial anti-gout effect conferred by common and rare dysfunctional variants of URAT1/SLC22A12.
Toyoda Y et al.
Rheumatology (oxford, England), 2021
Contribution of SLC22A12 on hypouricemia and its clinical significance for screening purposes.
Cha DH et al.
Scientific Reports, 2019
Renal hypouricemia caused by novel compound heterozygous mutations in the SLC22A12 gene: a case report with literature review.
Zhou Z et al.
Bmc Medical Genetics, 2018
Depletion of Uric Acid Due to SLC22A12 (URAT1) Loss-of-Function Mutation Causes Endothelial Dysfunction in Hypouricemia.
Sugihara S et al.
Circulation Journal : Official Journal of the Japanese Circulation Society, 2015
Absence of SLC22A12 gene mutations in Greek Caucasian patients with primary renal hypouricaemia.
Tzovaras V et al.
Scandinavian Journal of Clinical and Laboratory Investigation, 2007
Mutations in human urate transporter 1 gene in presecretory reabsorption defect type of familial renal hypouricemia.
Wakida N et al.
The Journal of Clinical Endocrinology and Metabolism, 2005
Select a paper to view details